🇺🇸 FDA
Pipeline program

Menjugate

RSRSG 12-03

Approved mab completed

Quick answer

Menjugate for Meningococcal Disease is a Approved program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Meningococcal Disease
Phase
Approved
Modality
mab
Status
completed

Clinical trials